CMBA
OFIX icon

C.M. Bidwell & Associates’s Orthofix Medical OFIX Stock Holding History

C.M. Bidwell & Associates’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,085
Closed -$156K – 614
2021
Q3 		$156K Hold
4,085
– – 0.1% 191
2021
Q2 		$164K Sell
4,085
-105
-3% -$4.44K 0.11% 184
2021
Q1 		$182K Buy
4,190
+105
+3% +$4.63K 0.13% 153
2020
Q4 		$176K Buy
+4,085
New +$149K 0.14% 129

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

C.M. Bidwell & Associates's OFIX Position: Q4 2021 in Review

C.M. Bidwell & Associates sold out of Orthofix Medical (OFIX) in Q4 2021, closing a stake of 4,085 shares — an estimated $156K sold.

C.M. Bidwell & Associates first reported a position in OFIX in Q4 2020 and held it in 4 quarters. The position peaked at $182K in Q1 2021. 135 funds tracked by Wall St. Rank hold OFIX as of Q4 2021.

  • C.M. Bidwell & Associates reported no remaining Orthofix Medical position as of Q4 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 4,085 Orthofix Medical shares in Q4 2021, an estimated $156K.
  • C.M. Bidwell & Associates first reported a position in Orthofix Medical in Q4 2020 and held it in 4 quarters.
  • C.M. Bidwell & Associates's Orthofix Medical position peaked at $182K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.